Adial Pharmaceuticals, Inc. (ADIL)
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
$6.40M
Mr. Cary John Claiborne MBA
16.00
Charlottesville, VA
Jul 27, 2018
-0.25
$-3.99
4.89
5.69
-37,958.71%
-0.35
0.00
1.00
202.55
5.69
-247.34%
-291.06%
Similar stocks (15)
Benitec Biopharma Inc.
BNTC
Aileron Therapeutics, Inc.
ALRN
Reviva Pharmaceuticals Holdings, Inc.
RVPH
NeuroBo Pharmaceuticals, Inc.
NRBO
RenovoRx, Inc.
RNXT
Aeterna Zentaris Inc.
AEZS
Hoth Therapeutics, Inc.
HOTH
TransCode Therapeutics, Inc.
RNAZ
Pasithea Therapeutics Corp.
KTTA
Avenue Therapeutics, Inc.
ATXI
Tonix Pharmaceuticals Holding Corp.
TNXP
Bio-Path Holdings, Inc.
BPTH
Aditxt, Inc.
ADTX
Revelation Biosciences, Inc.
REVB
Better Therapeutics, Inc.
BTTX
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (15)
Benitec Biopharma Inc.
BNTC
Aileron Therapeutics, Inc.
ALRN
Reviva Pharmaceuticals Holdings, Inc.
RVPH
NeuroBo Pharmaceuticals, Inc.
NRBO
RenovoRx, Inc.
RNXT
Aeterna Zentaris Inc.
AEZS
Hoth Therapeutics, Inc.
HOTH
TransCode Therapeutics, Inc.
RNAZ
Pasithea Therapeutics Corp.
KTTA
Avenue Therapeutics, Inc.
ATXI
Tonix Pharmaceuticals Holding Corp.
TNXP
Bio-Path Holdings, Inc.
BPTH
Aditxt, Inc.
ADTX
Revelation Biosciences, Inc.
REVB
Better Therapeutics, Inc.
BTTX
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%